BMS Reports EMA’s Validation of MAA for Relatlimab and Nivolumab as 1L Treatment for Unresectable or Metastatic Melanoma Published: Oct 1, 2021 | Tags: BMS, EMA, MAA, Relatlimab, Nivolumab, Metastatic […]readmore
Tags : Medtronic
Shots: The company has received CE Mark for its radial artery access portfolio including Rist 079 radial access guide catheter and Rist radial access selective catheter to treat patients with […]readmore
Medtronic to Acquire Intersect ENT for ~$1.1B Published: Aug 6, 2021 | Tags: Medtronic, Intersect ENT, ~$1.1B Kite Signs a License Agreement with Appia to Develop Allogeneic Cell Therapies for […]readmore
Shots: Medtronic to acquire all outstanding shares of Intersect ENT for $28.25/ share in cash, making a total deal value of ~$1.1B. The transaction is expected to be completed by […]readmore
Shots: The real-world clinical study compares glycemic outcomes for 1,736 individuals before & after using the InPen smart insulin pen for 90days with a CGM & showed a 2.3% increase […]readmore
The medical devices industry is a fast-growing market driven by the complex needs of patients encouraging life science companies to develop innovative therapies to improve health and QoL In 2020, […]readmore
AzurRx BioPharma Reports Positive Interim P-II Data of MS1819 + PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency Published: May 14, 2021 | Tags: AzurRx BioPharma, P-II, MS1819, […]readmore
Shots: The company launches SonarMed airway monitoring system to detect ETT obstruction and confirms the real-time position by using acoustic technology and provides immediate, actionable intelligence for clinicians The SonarMed […]readmore
AstraZeneca Reports Results of Imfinzi (durvalumab) and Imfinzi + Tremelimumab in P-III POSEIDON Study as 1L Treatment for Stage IV Non-Small Cell Lung Cancer Published: May 7, 2021 | Tags: […]readmore
Shots: Medtronic launches CareGuidePro, a mobile app and first online portal for patients to navigate their spinal cord stimulation therapy journey. The app is developed in partnership with Higgs Boson […]readmore